Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PhotoniCare’s OtoSight Middle Ear Scope has received FDA clearance and demonstrated over 90% accuracy in detecting middle ear effusion. In a large randomized controlled trial published May 2025, the device enabled more accurate diagnosis of pediatric ear infections and led to a reported ~50% reduction in antibiotic usage compared to standard care. The company’s clinical data supports improved outcomes and reduced unnecessary antibiotic prescriptions for children with suspected otitis media.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PhotoniCare.